| Study |
Reference |
|
Anderka, 2012
|
Anderka Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol 2012; 94:22-30
|
|
Andersen (Controls exposed to clarithromycin), 2013
|
Andersen Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study. PLoS ONE 2013; 8:e53327
|
|
Andersen (Controls exposed to other treatment, sick), 2012
|
Andersen Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study. Aliment. Pharmacol. Ther. 2012; 35:1190-8
|
|
Andersen (Controls unexposed NOS), 2012
|
Andersen Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study. Aliment. Pharmacol. Ther. 2012; 35:1190-8
|
|
Andersen (Controls unexposed, NOS), 2013
|
Andersen Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study. PLoS ONE 2013; 8:e53327
|
|
Bànhidy - Omeprazole, 2011
|
Bànhidy Peptic ulcer disease with related drug treatment in pregnant women and congenital abnormalities in their offspring. Congenit Anom (Kyoto) 2011; 51:26-33
|
|
Breddels, 2022
|
Breddels Population-based cohort study: proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse events. BMC Med 2022; 20:492
|
|
Cea Soriano, 2016
|
Cea Soriano Exposure to acid-suppressing drugs during pregnancy and the risk of asthma in childhood: an observational cohort study. Aliment. Pharmacol. Ther. 2016; 43:427-37 Cea Soriano Association between exposure to acidsuppressing drugs during pregnancy and asthma in childhood Pharmacoepidemiol. Drug Saf. 2015; 24:242-.
|
|
Choi (Controls exposed to other treatment, sick), 2021
|
Choi Exploration of Proton Pump Inhibitors Use During Pregnancy and Preeclampsia. JAMA Netw Open 2021; 4:e2124339
|
|
Choi (Controls unexposed NOS), 2021
|
Choi Exploration of Proton Pump Inhibitors Use During Pregnancy and Preeclampsia. JAMA Netw Open 2021; 4:e2124339
|
|
Choi a, 2023
|
Choi Association Between Proton Pump Inhibitor Use During Early Pregnancy and Risk of Congenital Malformations. JAMA Netw Open 2023; 6:e2250366
|
|
Choi b, 2023
|
Choi Maternal Proton Pump Inhibitor Use During Pregnancy and Risk of Low Birth Weight in Offspring in Korea, 2008-2019. JAMA Netw Open 2023; 6:e237962
|
|
Cluver - Esomeprazole, 2018
|
Cluver Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial. Am. J. Obstet. Gynecol. 2018; 219:388.e1-388.e17
|
|
Colvin, 2011
|
Colvin Dispensing patterns and pregnancy outcomes in women dispensed proton pump inhibitors during pregnancy Pharmacoepidemiol Drug Saf. 2011;20:S45-S46
|
|
Dehlink (Controls exposed to other treatment, sick), 2009
|
Dehlink First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a population-based register study. Clin. Exp. Allergy 2009; 39:246-53
|
|
Dehlink (Controls unexposed NOS), 2009
|
Dehlink First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a population-based register study. Clin. Exp. Allergy 2009; 39:246-53
|
|
Diav-Citrin, 2005
|
Diav-Citrin The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment. Pharmacol. Ther. 2005; 21:269-75
|
|
Fejzo - Lansoprazole, 2015
|
Fejzo MS Neurodevelopmental delay in children exposed in utero to hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol 2015;189:79-84
|
|
Fejzo - Lansoprazole, 2013
|
Fejzo Antihistamines and other prognostic factors for adverse outcome in hyperemesis gravidarum. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 170:71-6
|
|
Hak, 2013
|
Hak Use of acid-suppressive drugs in pregnancy and the risk of childhood asthma: bidirectional crossover study using the general practice research database. Drug Saf 2013; 36:1097-104
|
|
Hastie, 2019
|
Hastie Proton Pump Inhibitors and Preeclampsia Risk Among 157 720 Women. Hypertension 2019; 73:1097-1103 Hastie, R. Incidence of preeclampsia among women using proton pump inhibitors during pregnancy & it-a swedish population register based cohort study Reprod. Sci. 2019; 26:387A-.
|
|
Källèn, 1998
|
Källén Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole. Br J Obstet Gynaecol 1998; 105:877-81
|
|
Källén, 2003
|
Källén Maternal drug use in early pregnancy and infant cardiovascular defect Reproductive Toxicology 2003; 17:255-.
|
|
Källén - Omeprazole, 2001
|
Källén Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001; 96:63-8
|
|
Kerr, 2018
|
Kerr Risk factors for congenital microcephaly in the pre-Zika era. Birth Defects Res 2019; 111:96-118
|
|
Lalkin - Omeprazole (Controls exposed to other treatment, sick), 1998
|
Lalkin The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am. J. Obstet. Gynecol. 1998; 179:727-30
|
|
Lalkin - Omeprazole (Controls unexposed NOS), 1998
|
Lalkin The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am. J. Obstet. Gynecol. 1998; 179:727-30
|
|
Lind, 2013
|
Lind Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007. Pharmacoepidemiol Drug Saf 2013; 22:783-93
|
|
Malaeb, 2021
|
Malaeb Preconception exposure to over-the-counter medications and antibiotics and the risk of childhood asthma in Lebanon: A cross-sectional study. Allergol Immunopathol (Madr) 2021; 49:104-112
|
|
Matok, 2012
|
Matok The safety of fetal exposure to proton-pump inhibitors during pregnancy. Dig. Dis. Sci. 2012; 57:699-705
|
|
Moretti, 2002
|
Moretti (cited by Nikfar 2002) Use of proton pump inhibitors during pregnancy and rates of major malformations (Personal communication). 2002
|
|
Mulder, 2014
|
Mulder Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: a cohort study. Clin. Exp. Allergy 2014; 44:261-9
|
|
Munch, 2014
|
Munch Risk factors for congenital hydrocephalus: a nationwide, register-based, cohort study. J. Neurol. Neurosurg. Psychiatry 2014; 85:1253-9
|
|
Nielsen, 1999
|
Nielsen The safety of proton pump inhibitors in pregnancy. Aliment. Pharmacol. Ther. 1999; 13:1085-9
|
|
Noh, 2023
|
Noh Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in Children. JAMA Pediatr 2023; 177:267-277
|
|
Pasternak, 2010
|
Pasternak Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N. Engl. J. Med. 2010; 363:2114-23
|
|
Rhim, 2010
|
Rhim Maternal use of proton pump inhibitors (PPI) during pregnancy is associated with an increased risk for cardiac birth defects: analysis of 208,951 pregnancies from the THIN database Pharmacoepidemiol Drug Saf. 2010;138:S63
|
|
Ruigomez - Omeprazole (Controls exposed to other treatment, sick), 1999
|
Ruigomez Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am. J. Epidemiol. 1999; 150:476-81
|
|
Ruigomez - Omeprazole (Controls unexposed NOS), 1999
|
Ruigomez Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am. J. Epidemiol. 1999; 150:476-81
|
|
Saleh, 2017
|
Saleh Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors. Hypertension 2017; 70:594-600
|
|
Van Gelder, 2022
|
Van Gelder Associations Between Late-Onset Preeclampsia and the Use of Calcium-Based Antacids and Proton Pump Inhibitors During Pregnancy: A Prospective Cohort Study. Clin Epidemiol 2022; 14:1229-1240
|
|
Werler, 2014
|
Werler Medication use in pregnancy in relation to the risk of isolated clubfoot in offspring. Am. J. Epidemiol. 2014; 180:86-93
|
|
Wolfe (Controls exposed to other treatment, sick), 2019
|
Wolfe Prenatal use of medications for gastroesophageal reflux disease and early childhood fracture risk. Birth 2019; 46:656-662
|
|
Wolfe (Controls unexposed NOS), 2019
|
Wolfe Prenatal use of medications for gastroesophageal reflux disease and early childhood fracture risk. Birth 2019; 46:656-662
|
|
Yitshak-Sade, 2016
|
Yitshak-Sade Prenatal exposure to H2 blockers and to proton pump inhibitors and asthma development in offspring. J Clin Pharmacol 2016; 56:116-23
|
